Morris & Dickson Acquires Prodigy Health

January 26, 2026

Morris & Dickson has completed the acquisition of Prodigy Health (now operating as ProdigyMD), a specialty pharmaceutical distributor focused on plasma-derived therapies. The acquisition expands Morris & Dickson's specialty distribution capabilities and access to hospitals, specialty pharmacies, clinics, infusion centers and alternative sites of care while preserving operational continuity and regulatory compliance.

Buyers
Morris & Dickson
Targets
Prodigy Health
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.